Advertisement

Inflammation Research

, Volume 68, Issue 5, pp 359–368 | Cite as

Age-dependent hepatic alterations induced by a high-fat high-fructose diet

  • B. P. Casagrande
  • M. F. P. Gomes
  • E. O. C. Moura
  • A. C. C. Santos
  • M. C. Kubota
  • D. A. Ribeiro
  • L. P. Pisani
  • A. Medeiros
  • D. EstadellaEmail author
Original Research Paper
  • 50 Downloads

Abstract

Objective

The present study aimed to evaluate and clarify how the age at which the intake of a high-fat and high-fructose diet begins can affect animals’ livers.

Methods

Thirty-eight male wistar rats aged 6 and 12 weeks were fed a high-fat and high-fructose diet for 13 weeks. Inflammatory cytokines, hepatic glycogen, serum and hepatic triacylglycerol and pAkt protein content in the liver were assessed. Percentage of weight gained, and visceral adiposity were also evaluated.

Results

Young animal presented increased hepatic triacylglycerol and decreased glycogen, while adult animals had no significant alterations regarding its contents. IL6 and IL10 to IL6 ratio were also altered in young animals exposed to HFHF, while adult animals fed with HFHF had only increases in TNF-α. Both groups which received HFHF had increased serum triacylglycerol and visceral adiposity. However, only young animals gained more relative weight and had greater final body weight, gains which were related to alterations found in hepatic triacylglycerol and glycogen.

Conclusion

Age of which consumption begins interferes in how the liver deals with an excess of nutrient and subsequent proinflammatory stimulation, leading to different phenotypes.

Keywords

Age-dependent Inflammation IL6 TNF-α Hepatic triacylglycerol Hepatic glycogen 

Notes

Acknowledgements

This work was supported in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-Brazil - Financial Code 001) and by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP #2015/19893-0).

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest.

References

  1. 1.
    Keating C, Backholer K, Gearon E, Stevenson C, Swinburn B, Moodie M, et al. Prevalence of class-I, class-II and class-III obesity in Australian adults between 1995 and 2011–12. Obes Res Clin Pract. 2015;9:553–62 (Asia Oceania Assoc. for the Study of Obesity).CrossRefGoogle Scholar
  2. 2.
    Halloran L. Obesity: the new epidemic. J Nurse Pract. 2014;10:362–3.CrossRefGoogle Scholar
  3. 3.
    van der Merwe M-T. Psychological correlates of obesity in women. Int J Obes. 2007;31:14–8.CrossRefGoogle Scholar
  4. 4.
    Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.CrossRefGoogle Scholar
  5. 5.
    Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9:13–27.CrossRefGoogle Scholar
  6. 6.
    González Jiménez E, Obesity. Etiologic and pathophysiological analysis. Endocrinol y Nutr. 2012;60:17–24.CrossRefGoogle Scholar
  7. 7.
    WHO. Obesity and overweight [Internet]. Obes. overweight. World Health Organization. 2019. http://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 9 Feb 2019.
  8. 8.
    GBD. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2013;2015;386:743–800.Google Scholar
  9. 9.
    Zelber-Sagi S. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol. 2011;17:3377.CrossRefGoogle Scholar
  10. 10.
    Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11:1–16.CrossRefGoogle Scholar
  11. 11.
    Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3–9.CrossRefGoogle Scholar
  12. 12.
    Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R, et al. Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience. 2015.Google Scholar
  13. 13.
    Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–404.CrossRefGoogle Scholar
  14. 14.
    Wang O, Liu J, Cheng Q, Guo X, Wang Y, Zhao L, et al. Effects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats. PLoS One. 2015;10:e0118135.CrossRefGoogle Scholar
  15. 15.
    Woodie L, Blythe S. The differential effects of high-fat and high-fructose diets on physiology and behavior in male rats. Nutr Neurosci. 2017;0:1–9.Google Scholar
  16. 16.
    Toklu HZ, Muller-Delp J, Sakaraya Y, Oktay S, Kirichenko N, Matheny M, et al. High dietary fructose does not exacerbate the detrimental consequences of high fat diet on basilar artery function. J Physiol Pharmacol. 2016;67:205–16.Google Scholar
  17. 17.
    Estadella D, Oyama LM, Dâmaso AR, Ribeiro EB, Oller Do Nascimento CM. Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition. 2004;20:218–24.CrossRefGoogle Scholar
  18. 18.
    Vatner DF, Majumdar SK, Kumashiro N, Petersen MC, Rahimi Y, Gattu AK, et al. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. Proc Natl Acad Sci. 2015;112:1143–8.CrossRefGoogle Scholar
  19. 19.
    Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond). 2016;13:15.CrossRefGoogle Scholar
  20. 20.
    Totsch SK, Quinn TL, Strath LJ, McMeekin LJ, Cowell RM, Gower BA, et al. The impact of the Standard American Diet in rats: effects on behavior, physiology and recovery from inflammatory injury. Scand J Pain. 2017;17:316–24.CrossRefGoogle Scholar
  21. 21.
    Jump DB, Depner CM, Tripathy S, Lytle K, et al. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer. Adv Nutr. 2015;6:694–702.CrossRefGoogle Scholar
  22. 22.
    Tranchida F, Shintu L, Rakotoniaina Z, Tchiakpe L, Deyris V, Hiol A, et al. Metabolomic and lipidomic analysis of serum samples following Curcuma longa extract supplementation in high-fructose and saturated fat fed rats. PLoS One. 2015;10:1–19.CrossRefGoogle Scholar
  23. 23.
    Rocha DM, Caldas AP, Oliveira LL, Bressan J, Hermsdorff HH. Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis. 2016;244:211–5.CrossRefGoogle Scholar
  24. 24.
    Martín-Hernández D, Caso JR, Bris ÁG, Maus SR, Madrigal JLM, García-Bueno B, et al. Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats. Neuropharmacology. 2016;103:122–33.CrossRefGoogle Scholar
  25. 25.
    Hassan W, Ding L, Gao R-Y, Liu J, Shang J. Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine. 2014;66:133–42.CrossRefGoogle Scholar
  26. 26.
    Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of Interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003;278:13740–6.CrossRefGoogle Scholar
  27. 27.
    Lu B, Bridges D, Yang Y, Fisher K, Cheng A, Chang L, et al. Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity. Diabetes. 2014;63:2935–48.CrossRefGoogle Scholar
  28. 28.
    Kim M-S, Krawczyk SA, Doridot L, Fowler AJ, Wang JX, Trauger SA, et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016;126:4372–86.CrossRefGoogle Scholar
  29. 29.
    Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, et al. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med. 2009;47:1067–74.CrossRefGoogle Scholar
  30. 30.
    Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein AH. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:833–49.CrossRefGoogle Scholar
  31. 31.
    Varela-Rey M, Embade N, Ariz U, Lu SC, Mato JM, Martínez-Chantar ML. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol. 2009;41:969–76.CrossRefGoogle Scholar
  32. 32.
    Estadella D, Oyama LM, Bueno AA, Habitante CA, Souza GI, Ribeiro EB, et al. A palatable hyperlipidic diet causes obesity and affects brain glucose metabolism in rats. Lipids Health Dis. 2011;10:168.CrossRefGoogle Scholar
  33. 33.
    Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2012;23:203–8.CrossRefGoogle Scholar
  34. 34.
    Lim JS, Mietus-Snyder M, Valente A, Schwarz J-M, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7:251–64.CrossRefGoogle Scholar
  35. 35.
    Iossa S, Lionetti L, Mollica MP, Barletta A, Liverini G. Energy intake and utilization vary during development in rats. J Nutr. 1999;129:1593–6.CrossRefGoogle Scholar
  36. 36.
    de Castro UGM, dos Santos RAS, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis. 2013;12:136.CrossRefGoogle Scholar
  37. 37.
    Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.CrossRefGoogle Scholar
  38. 38.
    Balmain JH, Biggers J, Claringbold P. Micromethod for the estimation of glycogen in the genital organs of the, mouse. Aust J Biol Sci. 1956.Google Scholar
  39. 39.
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.Google Scholar
  40. 40.
    Santamarina A, Jamar G, Mennitti L, de Rosso V, Cesar H, Oyama L, et al. The Use of Juçara (Euterpe edulis Mart.) supplementation for suppression of NF-κB pathway in the hypothalamus after high-fat diet in Wistar rats. Molecules. 2018;23:1814.CrossRefGoogle Scholar
  41. 41.
    Crescenzo R, Bianco F, Coppola P, Mazzoli A, Tussellino M, Carotenuto R, et al. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats. Exp Physiol. 2014;99:1203–13.CrossRefGoogle Scholar
  42. 42.
    Santamarina AB, Carvalho-Silva M, Gomes LM, Okuda MH, Santana AA, Streck EL, et al. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. J Nutr Biochem. 2015;26:1348–56.CrossRefGoogle Scholar
  43. 43.
    Liu X, Xue Y, Liu C, Lou Q, Wang J, Yanagita T, et al. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis. 2013;12:109.CrossRefGoogle Scholar
  44. 44.
    Yamaguchi K, Nishimura T, Ishiba H, Seko Y, Okajima A, Fujii H, et al. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. Liver Int. 2015;35:550–61.CrossRefGoogle Scholar
  45. 45.
    Krahenbuhl L, Lang C, Ludes S, Seiler C, Schafer M, Zimmermann A, et al. Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int. 2003;23:101–9.CrossRefGoogle Scholar
  46. 46.
    Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, et al. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J Nutr Biochem. 2015;26:1183–92.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • B. P. Casagrande
    • 1
  • M. F. P. Gomes
    • 1
  • E. O. C. Moura
    • 1
  • A. C. C. Santos
    • 2
  • M. C. Kubota
    • 1
  • D. A. Ribeiro
    • 3
  • L. P. Pisani
    • 3
  • A. Medeiros
    • 3
  • D. Estadella
    • 3
    Email author
  1. 1.Programa de Pós-Graduação Interdisciplinar em Ciências da SaúdeUniversidade Federal de São PauloSantosBrazil
  2. 2.Instituto de Saúde e SociedadeUniversidade Federal de São PauloSantosBrazil
  3. 3.Departamento de Biociências, Instituto de Saúde e SociedadeFederal University of São Paulo (UNIFESP)SantosBrazil

Personalised recommendations